ARK Genomic (Switzerland) Performance
| ARKG Etf | 4.26 0.25 5.54% |
The etf shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ARK Genomic's returns are expected to increase less than the market. However, during the bear market, the loss of holding ARK Genomic is expected to be smaller as well.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ARK Genomic are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, ARK Genomic is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
1 | Cathie Wood Goes All-In On Peter Thiels Crypto Play Bullish With Back-To-Back Million-Dollar Buys - MSN | 11/05/2025 |
2 | Why Tempus AI Stock Soared This Week - The Motley Fool | 11/28/2025 |
3 | cathie woods ark stock trades major robinhood buy, ibotta sell By Investing.com - Investing.com Canada | 12/11/2025 |
4 | RBLX, META, GH, IONS Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks - TipRanks | 01/06/2026 |
5 | Cathie Woods ARK adds to Joby Aviation, trims Teradyne stock By Investing.com - Investing.com South Africa | 01/29/2026 |
ARK |
ARK Genomic Relative Risk vs. Return Landscape
If you would invest 417.00 in ARK Genomic on November 7, 2025 and sell it today you would earn a total of 9.00 from holding ARK Genomic or generate 2.16% return on investment over 90 days. ARK Genomic is generating 0.0745% of daily returns and assumes 2.7887% volatility on return distribution over the 90 days horizon. Simply put, 25% of etfs are less volatile than ARK, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ARK Genomic Target Price Odds to finish over Current Price
The tendency of ARK Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.26 | 90 days | 4.26 | about 87.09 |
Based on a normal probability distribution, the odds of ARK Genomic to move above the current price in 90 days from now is about 87.09 (This ARK Genomic probability density function shows the probability of ARK Etf to fall within a particular range of prices over 90 days) .
ARK Genomic Price Density |
| Price |
Predictive Modules for ARK Genomic
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ARK Genomic. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ARK Genomic Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ARK Genomic is not an exception. The market had few large corrections towards the ARK Genomic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ARK Genomic, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ARK Genomic within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.60 | |
σ | Overall volatility | 0.23 | |
Ir | Information ratio | -0.06 |
ARK Genomic Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ARK Genomic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ARK Genomic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Latest headline from news.google.com: Cathie Woods ARK adds to Joby Aviation, trims Teradyne stock By Investing.com - Investing.com South Africa |
About ARK Genomic Performance
Evaluating ARK Genomic's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if ARK Genomic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ARK Genomic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
ARK Genomic is entity of Switzerland. It is traded as Etf on SW exchange.| Latest headline from news.google.com: Cathie Woods ARK adds to Joby Aviation, trims Teradyne stock By Investing.com - Investing.com South Africa |
Other Information on Investing in ARK Etf
ARK Genomic financial ratios help investors to determine whether ARK Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ARK with respect to the benefits of owning ARK Genomic security.